JAMIE GARRETT: Open Payments
NPI 1679050728 · COTTONPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 10 payments from 9 companies in 2025. Trend: 2023 $277 · 2024 $268 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Ardelyx, Inc. | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Corium, LLC | 2 | $15 |
Products named: JARDIANCE, VRAYLAR, CAPLYTA, IBSRELA, JOURNAVX, OTEZLA, Azstarys.
Industry payments across LA — which companies pay providers there.
